pharmaphorum

JUNE 8, 2021

The possibility of data being shared with third-parties including academic researchers and pharmaceutical companies – albeit pseudonymised – has raised concerns about whether the public is aware that they stand to lose control of private information on their physical, mental and sexual health.

Medical Records

European Pharmaceutical Review

SEPTEMBER 22, 2022

Dr Maier has over 25 years of experience in drug development and commercialisation at pharmaceutical companies in Europe, Canada, the United States and Asia. 2013 Oct; 48(10): 943–953. Published online 2013 Jul 2. Mayer-Hamblett N, Rosenfeld M, Treggiari MM et al. Pediatr Pulmonol. doi: 1002/ppul.22693. Thompson, LA.

Drug Development

pharmaphorum

AUGUST 23, 2021

The possibility of data being shared with third-parties including academic researchers and pharmaceutical companies raised concerns about whether the public is aware that they stand to lose control of private information on their physical, mental and sexual health. Now that’s been set back indefinitely. survey conducted in July.

Medical Records

Pharmaceutical Technology

OCTOBER 25, 2022

Pharmaceutical companies – and the FDA – are embracing FDCs. From 1990 through 2013, the FDA approved 131 FDC products, on average 5.7 The potential to extend the patent life and market exclusivity of a company’s APIs is a potent financial incentive. More FDC products flowing into pharma pipelines.

Dosage

European Pharmaceutical Review

SEPTEMBER 25, 2023

Gregory’s industrial career spans an employment history with several major pharmaceutical companies. 2013; 102(1): 52–61. He obtained his BS in Chemistry from St Xavier College, MS in Analytical Chemistry from Governors State University and a PhD in Analytical Chemistry from Northern Illinois University. 2007; 848(1): 79–87.

Compounding

pharmaphorum

MAY 14, 2021

Practically though, there are risks of additional processes and requirements (and expense) for pharmaceutical companies. It is also possible that companies may prefer to enter the EU market through the EMA process and avoid additional processes involving the MHRA and NICE.

Drug Pricing

Pharmaceutical Technology

OCTOBER 5, 2022

Ferry describes a popular solution among pharmaceutical companies. Some companies try to separate the clinical educational programs from their sales programs, and the speaker programs are run through the clinical education programs. BIIB107 is a monoclonal antibody that targets ?4

Documentation

RX Note

MARCH 28, 2023

Malaysia At Pharmacy Board 101th Meeting on 30th September 2013, minimum number of CPD points per year is set at 30 for renewal of Pharmacist Annual Retention. As the Code of Ethics for Pharmacists 2018 emphasizes, it is essential to engage in continuous professional development (CPD).

Hospitals

European Pharmaceutical Review

NOVEMBER 8, 2022

European pharmaceutical companies targeting the US market should be aware of these pending bills and their potential impacts on market entry, intellectual property enforcement and payer access. 136 (2013), [link] opinions/12pdf/12-416_m5n0.pdf. 3) policing anticompetitive settlements between competing drug manufacturers.

Biosimilars

pharmaphorum

MAY 26, 2021

The government’s last attempt to shake up patient data-sharing – 2013’s Care.data scheme – suffered from a number of false starts and was eventually shut down in 2016. People can opt out of the scheme by filling in a form and taking it to their GP before 23 June, but campaigners say this has not been communicated effectively.

Communication

pharmaphorum

JANUARY 14, 2021

Not so China, and especially not so the lead five European countries – on average European pharmaceutical companies saw a loss of 30% of the interactive time they previously had with healthcare professionals in 2020. Up to November, the US and Japan actually saw increases in interactive time in 2020. Pharma pivots East.

Biosimilars

European Pharmaceutical Review

MARCH 11, 2024

Employing MALDI-TOF MS for microbial identification in sterile drug manufacturing Fungal contamination in pharmaceutical cleaning facilities Case study examples Mould and yeast have been reported by several previous authors in numerous pharmaceutical cleanrooms , cold rooms, and controlled areas, according to the authors. Ahmed et al.

Sterile Compounds

European Pharmaceutical Review

OCTOBER 19, 2022

Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. 23 April 2013.

Biosimilars

European Pharmaceutical Review

FEBRUARY 1, 2024

In this Q&A, he explores the trends and challenges within the cardiovascular treatment space, as well as clinical development of the company’s lead candidate obicetrapib, a cholesterol ester transfer protein (CETP) inhibitor for lowering low-density lipoprotein-cholesterol (LDL-C) and ultimately reducing cardiovascular risk.

Documentation

Pharmaceutical Technology

NOVEMBER 4, 2022

The SME R&D tax credit scheme allows tax relief of up to 33% on qualifying R&D expenditure, which the former PM David Cameron’s cabinet introduced in April 2013. Furthermore, O’Meara says it would be important to standardize intellectual property (IP) policy to avoid confusion for researchers and companies. says O’Meara.

Documentation

Pharmaceutical Technology

SEPTEMBER 22, 2022

The pharmaceutical company is well on its way to achieving its goals with successful full reimbursements, already confirmed in the United Kingdom ( UK), and Sweden. GlobalData is the parent company of Pharmaceutical Technology. Following this, in 2019, the FDA approved Vazkepa for the reduction of cardiovascular risk.

Pharmaceutical Companies

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines

The Thyroid Pharmacist

OCTOBER 28, 2022

Allegedly, the inventor left the company, along with his proprietary recipe, and the product that the VSL #3 manufacturer has been making is different than the clinically tested product. Published 2013 Apr 18. doi:10.1155/2013/767482. ScientificWorldJournal. 2013;2013:767482. Rodrigues AC, Cara DC, Fretez SH, et al.

Health and Personal Care Stores

PharmaShots

APRIL 12, 2023

Total Revenue: $28.54B Founded Year: 1876 Total Employees: ~21,000 Headquarters: Indianapolis, United States Market Cap: $344.98B Stock Exchange: NYSE With an idea to produce quality products, Eli Lilly and Company is an American Pharmaceutical company focused on discovering, developing, manufacturing, and marketing these products.

Diabetes

European Pharmaceutical Review

JANUARY 16, 2023

” Tony Cundell: Contract manufacturing organisations (CROs), start-up companies, established pharmaceutical companies and regulatory agencies are having difficulty recruiting and retaining technically-trained personnel. Dr Tony Cundell has a PhD in Microbiology from the Lincoln University, New Zealand.

Vaccines

PharmaShots

MARCH 29, 2023

Shots: Drug patent expiry is when a patent granted to a pharmaceutical company for a particular drug expires, allowing other companies to produce and sell generic versions Like every other utility patent, pharmaceuticals also get market exclusivity of 20 years. Currently, the drug is not accessible in generic form.

Biosimilars

The Thyroid Pharmacist

OCTOBER 27, 2023

The truth is that most supplement companies do not undergo the same scrutiny and testing that pharmaceutical products do, because many of the tests which are required of pharmaceutical companies are voluntary for supplement companies. Published 2013 Dec 26. 2013-3950. [30] Adv Exp Med Biol.

Health and Personal Care Stores

Pharmaceutical Technology

APRIL 24, 2023

The US accounts for almost half of all biotechnology patents filed worldwide from 1999 to 2013. As a result, some pharmaceutical companies are turning to third parties. According to a Brookings study, the US has always been a global leader in the sector. Moreover, skilled manpower is required to run these facilities.

Vaccines

The Thyroid Pharmacist

JULY 7, 2023

I really wish that this supplement would come back, and it’s one of the drug entities I would like to create if I ever win the lottery and start my own pharmaceutical company. The Journal of Clinical Endocrinology and Metabolism 2013:0021-972X. [60] The Journal of Clinical Endocrinology and Metabolism 2013:0021-972X. [61]

Immunity

Express Pharma

MAY 31, 2025

Under the UCPMP, pharmaceutical companies can submit their self-declaration to their Industry Association (for uploading on their website) or, if the company is not a member of any such body or is a member of more than one, directly to the UCPMP portal of the Department of Pharmaceuticals (DoP).

Pharmaceutical Companies